Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors

PURPOSE: The purpose of this study was to evaluate the effect of optimally timed combination treatment with angiogenic and glycolytic inhibitors on tumor burden, hypoxia, and angiogenesis in advanced retinoblastoma tumors. METHODS: LH(BETA)T(AG) mice (n =30) were evaluated. Mice were divided into 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Houston, Samuel K, Piña, Yolanda, Murray, Timothy G, Boutrid, Hinda, Cebulla, Colleen, Schefler, Amy C, Shi, Wei, Celdran, Magda, Feuer, William, Merchan, Jaime, Lampidis, Ted J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037041/
https://www.ncbi.nlm.nih.gov/pubmed/21339806
http://dx.doi.org/10.2147/OPTH.S15179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037041/
https://www.ncbi.nlm.nih.gov/pubmed/21339806
http://dx.doi.org/10.2147/OPTH.S15179

Ejemplares similares